About Stylus Medicine
Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders. The company is based in Cambridge, Massachusetts.
Company details
Funding
Total raised
$85M
Last stage
Series A
Investors
Founders
Patrick Hsu
Scientific founder of Stylus Medicine. Co-founder of the Arc Institute and Assistant Professor of Bioengineering at UC Berkeley. His research on large serine recombinases underlies Stylus's gene insertion platform.
LinkedInEmile Nuwaysir
Serial biotech entrepreneur with 25+ years in cell and gene therapy. Previously CEO of BlueRock Therapeutics (Bayer) and Ensoma. Leads Stylus Medicine as Chairman and CEO.
Jason Fontenot
Chief Scientific Officer of Stylus Medicine, part of the founding leadership team alongside CEO Emile Nuwaysir.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.